Chin Augmentation Market Report 2025

This Chin Augmentation market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The chin augmentation market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing aesthetic awareness, increasing awareness of facial aesthetics, increasing the use of virtual consultations, and growing awareness of the importance of facial balance and harmony.

The chin augmentation market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for cosmetic procedures, growing financial accessibility to aesthetic procedures, growing cosmetic demand, growing demand for chin augmentation procedures, and rising aesthetic consciousness. Major trends in the forecast period include technological advancements, the introduction of new technologies and techniques, developments in next-generation dermal fillers, innovations in medical technologies, and innovations in surgical techniques.

The chin augmentation market is expected to expand due to the increasing popularity of cosmetic procedures. These medical treatments focus on improving appearance and addressing aesthetic concerns or physical imperfections. The rise in cosmetic procedures is driven by a growing societal emphasis on appearance and advancements in medical technology, which have made these treatments more accessible and safer. Chin augmentation is sought after for enhancing facial balance and profile aesthetics, contributing to its popularity in cosmetic enhancements. For example In June 2024, a report released by the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional non-governmental organization, highlighted that in 2023, the total number of surgical and non-surgical aesthetic procedures rose by 3.4%, reaching 34.9 million. Surgical procedures saw a higher increase of 5.5%, with over 15.8 million procedures performed by plastic surgeons, while non-surgical procedures accounted for 19.1 million. This growing trend in cosmetic procedures is fueling the expansion of the chin augmentation market.

Companies in the chin augmentation market are developing advanced medical solutions, such as hyaluronic acid (HA) dermal fillers, to meet the rising demand for non-surgical aesthetic enhancements and to offer safer, more effective options for facial feature improvement. Hyaluronic acid dermal fillers are gel-like substances injected into the skin to add volume, smooth wrinkles, and refine facial contours. For instance, in March 2024, AbbVie, a U.S.-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had approved its JUVÉDERM VOLUMA injectable gel for deep injection. This gel is indicated for correcting age-related volume loss in the mid-face through cheek augmentation, as well as for enhancing the chin profile in adults aged 21 and older.

In April 2024, Beverly JCG Ltd., a Singapore-based wellness and beauty company, acquired BK Aesthetic Clinic for an undisclosed amount. This acquisition aims to expand Beverly JCG Ltd.'s presence in the aesthetics and healthcare sectors, while leveraging the expertise and reputation of a well-known South Korean cosmetic surgeon to enhance its service offerings and financial performance. BK Aesthetic Clinic, based in Singapore, specializes in chin augmentation services.

Major companies operating in the chin augmentation market are AbbVie Inc., Stryker Corporation, Galderma Filler, Merz Pharma Gmbh and Co. Kgaa, InMode Ltd., KLS Martin Group, OsteoMed, Sientra Inc, GC Aesthetics Limited, Hans Biomed, POLYTECH Health and Aesthetics, Implantech Associates Inc, Sebbin Sas, Teoxane, Solta Medical Inc, Silimed, Lucid Implants, Surgiform Technologies, Facial Plastic Surgery Inc, Eurosurgical Ltd, Cadogan Clinic Ltd.

North America was the largest region in the chin augmentation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chin augmentation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chin augmentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Chin augmentation, also known as genioplasty or mentoplasty, is a cosmetic surgical procedure aimed at enhancing the contour, size, and projection of the chin. This procedure can involve using implants or reshaping the existing bone to create a more balanced facial profile. It is often sought to improve facial symmetry and overall aesthetics.

The main types of chin augmentation procedures are surgical and non-surgical. Surgical methods involve operative techniques to address aesthetic concerns, while non-surgical options use materials such as implants, dermal fillers, and fat grafting. These methods are suitable for both males and females and are performed in various settings, including hospitals, cosmetic clinics, and ambulatory surgical centers.

The chin augmentation market research report is one of a series of new reports that provides chin augmentation market statistics, including chin augmentation industry global market size, regional shares, competitors with a chin augmentation market share, detailed chin augmentation market segments, market trends and opportunities, and any further data you may need to thrive in the chin augmentation industry. This chin augmentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chin augmentation market consists of revenues earned by entities providing services such as chin surgery, chin augmentation with neck liposuction, chin reduction surgery, and revision chin surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The chin augmentation market also includes sales of surgical instruments and equipment, dermal fillers and injectables, facial implants and augmentation kits, and post-operative care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.